Physician profile
Christopher M Wright
NPI 1427041276
$1,569.79
in general payments reported to CMS, 2019-2025
17 companies · $514 in 2025
The $514 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $325 · 2020: $35.00 · 2021: $255 · 2023: $151 · 2024: $290 · 2025: $514.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $954.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $954.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $325.00 | 2019 | |
| Medtronic, INC. | $284.58 | 2021-2024 | Linq II |
| Amgen INC. | $278.37 | 2023-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $209.52 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $122.65 | 2024-2025 | Jardiance |
| Ucb, INC. | $93.48 | 2023 | Fintepla |
| Bardy Diagnostics, INC. | $50.00 | 2020-2021 | |
| Astrazeneca Pharmaceuticals Lp | $32.95 | 2023-2025 | Farxiga |
| Merck Sharp & Dohme LLC | $29.63 | 2025 | Verquvo |
| Alexion Pharmaceuticals, INC. | $20.19 | 2025 | Ultomiris |
| Vital Connect, INC | $20.16 | 2025 | Vitalpatch Rtm |
| Esperion Therapeutics, INC. | $19.17 | 2024 | Nexletol |
| Pfizer INC. | $18.93 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $17.92 | 2025 | Camzyos |
| Philips North America LLC | $17.27 | 2024 | (Ck7) Extended Holter |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $15.14 | 2025 | Tremfya |
| Janssen Pharmaceuticals, INC | $14.83 | 2024 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.